Outcomes of empirical ceftazidime avibactam plus colistin versus colistin regimens in carbapenem resistant…

Association of Carbapenemase Gene Profiles with Ceftazidime–avibactam Resistance in Carbapenem-Resistant Klebsiella pneumoniae
Elif Tuğçe Güner, Ayfer Bakır, Cemal Çiçek +1
International Journal of Molecular Sciences21 Oct 2026Peer-reviewedCC BY 4.0General medicineCrossref
Phenotypic and Genotypic Evaluation of Carbapenemases in Carbapenem-Resistant Klebsiella pneumoniae Isolates and Investigation of Ceftazidime-Avibactam and Colistin Susceptibility
Elif Gülsüm Torun, Elif Okumuş, Esra Kaya
International Journal of Molecular Sciences1 Oct 2026Peer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
In-Vitro Activity of Ceftazidime-Avibactam and Comparator Agents Against Carbapenem-Resistant Gram-Negative Isolates at a Tertiary Care Hospital in Lahore, Pakistan: A Cross-Sectional Study.
Faryal Yunus, Obaid Ur Rehman, Muhammad Murtaza +3
MicrobiologyOpen4 Nov 2026Peer-reviewedCC BYFull textGeneral medicineEurope PMC
Investigation on the use of ceftazidime-avibactam at a national hospital in Vietnam
Khue Dang Minh Van, Han Ngoc Bao Pham, An Thi Thanh Nguyen +4
PLOS One13 Oct 2026Peer-reviewedCC BY 4.0Full textMicrobiology Pharmacology & toxicologyPLOS
Relative inhibitory activities of taniborbactam and xeruborbactam against KPC variants conferring reduced susceptibility or resistance to ceftazidime/avibactam, cefiderocol, and cefepime/taniborbactam
Salud Rodríguez-Pallares, Christophe Le Terrier, Tania Blanco-Martín +10
Antimicrobial Agents and Chemotherapy4 Nov 2026Peer-reviewedCC BYFull textMicrobiology General medicineDOAJ

Cite

BibTeX

@article{muqtadir2026outcomes,
  title = {{Outcomes of empirical ceftazidime avibactam plus colistin versus colistin regimens in carbapenem resistant gram negative infection under diagnostic uncertainty}},
  author = {Jamil Muqtadir and Irshad Batool and Sameeullah Bhatti and Soman Rasool and Faryal Gohar and Abdul Rasheed and Urooj Fatima},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-71067-3},
  url = {https://www.nature.com/articles/s41598-026-71067-3},
  note = {CC BY-NC-ND 4.0},
}

RIS

TY  - JOUR
TI  - Outcomes of empirical ceftazidime avibactam plus colistin versus colistin regimens in carbapenem resistant gram negative infection under diagnostic uncertainty
AU  - Jamil Muqtadir
AU  - Irshad Batool
AU  - Sameeullah Bhatti
AU  - Soman Rasool
AU  - Faryal Gohar
AU  - Abdul Rasheed
AU  - Urooj Fatima
PY  - 2026
DA  - 2026/10/12
JO  - Scientific Reports
DO  - 10.1038/s41598-026-71067-3
UR  - https://www.nature.com/articles/s41598-026-71067-3
SN  - 2045-2322
ER  -

Related

Cite